China Probe Into H1N1 Vaccination Deaths Reveals Problems
This article was originally published in PharmAsia News
Executive SummaryA Chinese investigation into reports of fatalities and illnesses associated with H1N1 flu vaccinations in Shanxi Province has turned up cases of children becoming paralyzed. The director of Quangzhou Province CDC said an investigation showed some cases were linked to the vaccination program. Provincial authorities have not released a report of their investigation into the incidents. One case of a paralyzed child involved a 10-year-old boy who had not displayed symptoms of an illness before given the routine shots. The boy was unable to stand on his left leg the morning after the shot. (Click here for more
You may also be interested in...
The Chinese government's plan to reduce tariffs it imposed on a slew of US exports is expected to have minimal impact on the overall medtech industry. See what Ralph Ives, AdvaMed's executive VP for global strategy, said about it here.
FDA approved sNDAs from GlaxoSmithKline for diclofenac-containing Voltaren Arthritis Pain for the temporary relief of arthritis pain and from Alcon for Pataday olopatadine drops at 0.2% concentration for once-daily use temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair or dander and 0.1% for twice-daily use for the same indications plus redness relief.